• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

The Michael J. Fox Foundation - Articles and news items

nilotinib

Collaboration to explore nilotinib as a potential treatment for Parkinson’s

Industry news / 13 July 2016 / Victoria White, Digital Content Producer

Preclinical studies have shown that cancer drug nilotinib may protect neuronal cells from Parkinson’s pathology by inhibiting the activity of c-Abl…

nlife

nLife Therapeutics receives USD 350,000 from The Michael J. Fox Foundation for Parkinson’s Research

Industry news / 23 September 2014 / nLife Therapeutics

The funding will help characterize the mechanism of action of nLife’s lead compound NLF-PD-1233 in a Parkinson disease model and find a proper dose to engage clinical development…

H. Lundbeck A/S Logo 60x60

Lundbeck receives grant from The Michael J. Fox Foundation for biological markers identification in Parkinson’s disease

Industry news / 6 May 2014 / H. Lundbeck A/S

H. Lundbeck A/S has once again received support and recognition for its research on Parkinson’s disease through a grant from The Michael J. Fox Foundation for Parkinson’s Research…

H. Lundbeck A/S Logo 60x60

Lundbeck research projects secure funding from The Michael J. Fox Foundation

Industry news / 14 October 2013 / H. Lundbeck A/S

The Michael J. Fox Foundation has donated 5.5 million kroner to two Danish research projects in Parkinson’s disease…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +